Hypoxia modulates the effects of transforming growth factor-β isoforms on matrix-formation by primary human lung fibroblasts

Cytokine

Volumn 24, Issue 1-2, 2003, Pages 25-35

  Papakonstantinou, Eleni ^a   Aletras, Alexios J ^b   Roth, Michael ^c   Tamm, Michael ^c   Karakiulakis, George ^a  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^b UNIVERSITY OF PATRAS   (Greece)

^c UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

Collagen type I; Gelatinases; Interstitial collagenases; TGF ; TIMP

Indexed keywords

ACETIC ACID DERIVATIVE; AMINOPHENYLMERCURIC ACETATE; COLLAGEN TYPE 1; COLLAGENASE 3; GELATINASE A; GELATINASE B; INTERLEUKIN 6; INTERSTITIAL COLLAGENASE; TISSUE INHIBITOR OF METALLOPROTEINASE; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA2; TRANSFORMING GROWTH FACTOR BETA3; UNCLASSIFIED DRUG;

ARTICLE; COLLAGEN DEGRADATION; COLLAGEN SYNTHESIS; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME SYNTHESIS; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; HYPOXIA; LUNG FIBROBLAST; PRIORITY JOURNAL; PROTEIN CONTENT;

EID: 0141987850     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1043-4666(03)00253-9     Document Type: Article

References (52)

1. Dunsmore S.E., Rannels D.E. Extracellular matrix biology in the lung. Am J Physiol. 270:1996;L3-L27.
2. McAnulty R.J., Laurent G.J. Pathogenesis of lung fibrosis and potential new therapeutic strategies. Exp Nephrol. 3:1995;96-107.
3. Brand T., Schneider M.D. Transforming growth factor-β signal transduction. Circ Res. 78:1996;173-179.
4. Grande J.P. Role of transforming growth factor-β in tissue injury and repair. Proc Soc Exp Biol Med. 214:1997;27-40.
5. Coker R.K., Laurent G.J., Shahzeidi S., Lympany P.A., duBois R.M., Jeffery P.K., et al. Transforming growth factors-β1, -β2, and -β3 stimulate fibroblast procollagen production in vitro but are differentially expressed during bleomycin-induced lung fibrosis. Am J Pathol. 150:1997;981-991.
6. Branton M.H., Kopp J.B. TGF-beta and fibrosis. Microbes Infect. 1:1999;1349-1365.
7. Roberts A.B. Molecular and cell biology of TGF-beta. Miner Electrolyte Metab. 24:1998;111-119.
8. Eickelberg O., Kohler E., Reichenberger F., Bertschin S., Woodtli T., Erne P., et al. Extracellular matrix deposition by primary human lung fibroblasts in response to TGF-beta1 and TGF-beta3. Am J Physiol. 276:1999;L814-L824.
9. Papakonstantinou E., Roth M., Tamm M., Eickelberg O., Perruchoud A.P., Karakiulakis G. Hypoxia differentially enhances the effects of transforming growth factor-β isoforms on the synthesis and secretion of glycosaminoglycans by human lung fibroblasts. J Pharmacol Exp Ther. 301:2002;830-837.
10. Eickelberg O., Pansky A., Mussmann R., Bihl M., Tamm M., Hildebrand P., et al. Transforming growth factor-beta1 induces interleukin-6 expression via activating protein-1 consisting of JunD homodimers in primary human lung fibroblasts. J Biol Chem. 274:1999;12933-12938.
11. Murphy G., Knauper V. Relating matrix metalloproteinase structure to function: why the "hemopexin" domain? Matrix Biol. 15:1997;511-518.
12. Lotz M., Guerne P.A. Interleukin-6 induces the synthesis of tissue inhibitor of metalloproteinases-1/erythroid potentiating activity (TIMP-1/EPA). J Biol Chem. 266:1991;2017-2020.
13. Silacci P., Dayer J.M., Desgeorges A., Peter R., Manueddu C., Guerne P.A. Interleukin (IL)-6 and its soluble receptor induce TIMP-1 expression in synoviocytes and chondrocytes, and block IL-1-induced collagenolytic activity. J Biol Chem. 273:1998;13625-13629.
14. Ma C., Chegini N. Regulation of matrix metalloproteinases (MMPs) and their tissue inhibitors in human myometrial smooth muscle cells by TGF-β1. Mol Hum Reprod. 5:1999;950-954.
15. Schutte H., Lohmeyer J., Rosseau S., Ziegler S., Siebert C., Kielisch H., et al. Bronchoalveolar and systemic cytokine profiles in patients with ARDS, severe pneumonia and cardiogenic pulmonary oedema. Eur Respir J. 9:1996;1858-1867.
16. Miserocchi G., Passi A., Negrini D., Del Fabbro M., De Luca G. Pulmonary interstitial pressure and tissue matrix structure in acute hypoxia. Am J Physiol. 280:2001;L881-L887.
17. Kullmann A., Vaillant P., Muller V., Martinet Y., Martinet N. In vitro effects of pentoxifylline on smooth muscle cell migration and blood monocyte production of chemotactic activity for smooth muscle cells: potential therapeutic benefit in the adult respiratory distress syndrome. Am J Respir Cell Mol Biol. 8:1993;83-88.
18. Tamm M., Bihl M., Eickelberg O., Stulz P., Perruchoud A.P., Roth M. Hypoxia-induced interleukin-6 and interleukin-8 production is mediated by platelet activating factor and platelet-derived growth factor in primary human lung cells. Am J Respir Cell Mol Biol. 19:1998;653-661.
19. Papakonstantinou E., Karakiulakis G., Tamm M., Perruchoud A.P., Roth M. Hypoxia modifies the effect of PDGF on glycosaminoglycan synthesis by primary human lung cells. Am J Physiol. 279:2000;L825-L834.
20. Ramos C., Montano M., Garcia-Alvarez J., Ruiz V., Uhal B.D., Selman M., et al. Fibroblasts from idiopathic pulmonary fibrosis and normal lungs differ in growth rate, apoptosis, and tissue inhibitor of metalloproteinases expression. Am J Respir Cell Mol Biol. 24:2001;591-598.
21. Selman M., Ruiz V., Cabrera S., Segura L., Ramirez R., Barrios R., et al. TIMP-1, -2, -3, and -4 in idiopathic pulmonary fibrosis A prevailing nondegradative lung microenvironment? Am J Physiol. 279:2000;L562-L574.
22. Saed G.M., Zhang W., Diamond M.P. Molecular characterization of fibroblasts isolated from human peritoneum and adhesions. Fertil Steril. 75:2001;763-768.
23. Norman J.T., Clark I.M., Garcia P.L. Hypoxia promotes fibrogenesis in human renal fibroblasts. Kidney Int. 58:2000;2351-2366.
24. Moore B.A., Aznavoorian S., Engler J.A., Windsor L.J. Induction of collagenase-3 (MMP-13) in rheumatoid arthritis synovial fibroblasts. Biochim Biophys Acta. 1502:2000;307-318.
25. Slavin J., Unemori E., Hunt T.K., Amento E. Transforming growth factor beta (TGF-β) and dexamethasone have direct opposing effects on collagen metabolism in low passage human dermal fibroblasts in vitro. Growth Factors. 11:1994;205-213.
26. Orphanides C., Fine L.G., Norman J.T. Hypoxia stimulates proximal tubular cell matrix production via a TGF-beta1-independent mechanism. Kidney Int. 52:1997;637-647.
27. Fang K.C., Wolters P.J., Steinhoff M., Bidgol A., Blount J.L., Caughey G.H. Mast cell expression of gelatinases A and B is regulated by kit ligand and TGF-beta. J Immunol. 162:1999;5528-5535.
28. Gunther M., Haubeck H.D., van de Leur E., Blaser J., Bender S., Gutgemann I., et al. Transforming growth factor beta 1 regulates tissue inhibitor of metalloproteinases-1 expression in differentiated human articular chondrocytes. Arthritis Rheum. 37:1994;395-405.
29. Agocha A., Lee H.W., Eghbali-Webb M. Hypoxia regulates basal and induced DNA synthesis and collagen type I production in human cardiac fibroblasts: effects of transforming growth factor-beta1, thyroid hormone, angiotensin II and basic fibroblast growth factor. J Mol Cell Cardiol. 29:1997;2233-2244.
30. Mazzarelli P., Scuderi F., Mistretta G., Provenzano C., Bartoccioni E. Effect of transforming growth factor-beta1 on interleukin-6 secretion in human myoblasts. J Neuroimmunol. 87:1998;185-188.
31. Osawa H., Yamabe H., Inuma H., Miyata M., Sasaki T., Kaizuka M., et al. TGF-beta upregulates interleukin 6 production by rat glomerular epithelial cells in vitro. Nephrol Dial Transplant. 10:1995;1592-1597.
32. Coker R., Laurent K.G.J., Shahzeidi S., Hernandez-Rodriguez N.A., Pantelidis P., duBois R.M., et al. Diverse cellular TGF-β1 and TGF-β3 gene expression in normal human and murine lung. Eur Respir J. 9:1996;2501-2507.
33. Eickelberg O. Endless healing: TGF-L, SMADs, and fibrosis. FEBS Lett. 506:2001;11-14.
34. Khalil N., Greenberg A.H. The role of TGF-beta in pulmonary fibrosis. Ciba Found Symp. 157:1991;194-211.
35. Falanga V., Martin T.A., Takagi H., Kirsner R.S., Helfman T., Pardes J., et al. Low oxygen tension increases mRNA levels of alpha 1 (I) procollagen in human dermal fibroblasts. J Cell Physiol. 157:1993;408-412.
36. Ramos C., Montano M., Garcia-Alvarez J., Ruiz V., Uhal B.D., Selman M., et al. Fibroblasts from idiopathic pulmonary fibrosis and normal lungs differ in growth rate, apoptosis, and tissue inhibitor of metalloproteinases expression. Am J Respir Cell Mol Biol. 24:2001;591-598.
37. Corbel M., Belleguic C., Boichot E., Lagente V. Involvement of gelatinases (MMP-2 and MMP-9) in the development of airway inflammation and pulmonary fibrosis. Cell Biol Toxicol. 18:2002;51-61.
38. Saed G.M., Zhang W., Chegini N., Holmdahl L., Diamond M.P. Transforming growth factor beta isoforms production by human peritoneal mesothelial cells after exposure to hypoxia. Am J Reprod Immunol. 43:2000;285-291.
39. Akman H.O., Zhang H., Siddiqui M.A., Solomon W., Smith E.L., Batuman O.A. Response to hypoxia involves transforming growth factor-beta2 and Smad proteins in human endothelial cells. Blood. 98:2001;3324-3331.
40. Scheid A., Wenger R.H., Christina H., Camenisch I., Ferenc A., Stauffer U.G., et al. Hypoxia-regulated gene expression in fetal wound regeneration and adult wound repair. Pediatr Surg Int. 16:2000;232-236.
41. Spranger J., Meyer-Schwickerath R., Klein M., Schatz H., Pfeiffer A. Deficient activation and different expression of transforming growth factor-beta isoforms in active proliferative diabetic retinopathy and neovascular eye disease. Exp Clin Endocrinol Diabetes. 107:1999;21-28.
42. Li J.M., Datto M.B., Shen X., Hu P.P., Yu Y., Wang X.F. Sp1, but not Sp3, functions to mediate promoter activation by TGF-beta through canonical Sp1 binding sites. Nucleic Acids Res. 26:1998;2449-2456.
43. Chung K.Y., Agarwal A., Uitto J., Mauviel A. An AP-1 binding sequence is essential for regulation of the human alpha2(I) collagen (COL1A2) promoter activity by transforming growth factor-beta. J Biol Chem. 271:1996;3272-3278.
44. Alevizopoulos A., Dusserre Y., Tsai-Pflugfelder M., von der Weid T., Wahli W., Mermod N. A proline-rich TGF-beta-responsive transcriptional activator interacts with histone H3. Genes Dev. 9:1995;3051-3066.
45. Attisano L., Wrana J.L. Mads and Smads in TGF beta signalling. Curr Opin Cell Biol. 10:1998;188-194.
46. White L.A., Mitchell T.I., Brinckerhoff C.E. Transforming growth factor beta inhibitory element in the rabbit matrix metalloproteinase-1 (collagenase-1) gene functions as a repressor of constitutive transcription. Biochim Biophys Acta. 1490:2000;259-268.
47. Akira S., Kishimoto T. IL-6 and NF-IL6 in acute-phase response and viral infection. Immunol Rev. 127:1992;25-50.
48. 2+ in TGF-beta 1-induced IL-6 expression. J Immunol. 165:2000;2190-2197.
49. Sato T., Ito A., Mori Y. Interleukin 6 enhances the production of tissue inhibitor of metalloproteinases (TIMP) but not that of matrix metalloproteinases by human fibroblasts. Biochem Biophys Res Commun. 170:1990;824-829.
50. Karakiulakis G., Papanikolaou C., Jankovic S.M., Aletras A., Papakonstantinou E., Vretou E., et al. Increased type IV collagen-degrading activity in metastases originating from primary tumors of the human colon. Invasion Metastasis. 17:1997;158-168.
51. Syggelos S.A., Eleftheriou S.C., Giannopoulou E., Panagiotopoulos E., Aletras A.J. Gelatinolytic and collagenolytic activity in periprosthetic tissues from loose hip endoprostheses. J Rheumatol. 28:2001;1319-1329.
52. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 72:1976;248-254.